<DOC>
	<DOCNO>NCT01406015</DOCNO>
	<brief_summary>The purpose study find spironolactone , drug block action aldosterone , make blood vessel work well people obesity . The investigator also want find whether spironolactone cause change level insulin marker inflammation .</brief_summary>
	<brief_title>Mineralocorticoid Receptor Obesity Induced Cardiovascular Complications</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Mineralocorticoids</mesh_term>
	<criteria>1 . Age 1870 year 2 . Good health evidence history physical exam 3 . BMI : &gt; 30 kg/m2 &lt; 45 kg/m2 Exclusion criterion : 1 . Medical illness treat hypothyroidism 2 . BP &gt; 135/85 systolic BP &lt; 90 mm Hg 3 . Hepatic disease ( transaminase &gt; 3 time normal ) 4 . Renal impairment ( Creatinine clearance &lt; 60 ml/min ) 5 . Baseline serum K &gt; 5.0 mmol/L 6 . History drug alcohol abuse 7 . Allergies spironolactone 8 . Participation concurrent clinical trial 9 . Women use oral contraceptive within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Mineralocorticoid receptor</keyword>
</DOC>